A nagy rizikójú cardiovascularis betegek terá piája: Tényeken alapuló orvoslás

Translated title of the contribution: Drug therapy of high risk cardiovascular patients: Evidence Based Medicine

Gulácsi László, Kiss István

Research output: Contribution to journalArticle

Abstract

Ramipril is cost effective treatment for cardiovascular risk reduction in patients at medium, high and low pre-treatment risk. We suppose 300-700 thousand of patients to live in Hungary whose state of health would improve by taking ramipril. In the case of ramipril therapy, the estimated cost of one life year gained is 2.1-6.3 million HUF, depending on the specific age group (different risk portfolio). By the proper application of the therapy, probably, 2,0002,700 lives could be saved annually, and a five-year-long ramipril therapy would yield the save of approximately 30,000-50,000 life years.

Translated title of the contributionDrug therapy of high risk cardiovascular patients: Evidence Based Medicine
Original languageHungarian
Pages (from-to)269-279
Number of pages11
JournalOrvoskepzes
Volume77
Issue number4
Publication statusPublished - Dec 1 2002

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Drug therapy of high risk cardiovascular patients: Evidence Based Medicine'. Together they form a unique fingerprint.

  • Cite this